CVS Health Corporation operates an integrated health care model that combines retail pharmacy, pharmacy benefit management, health insurance, medical clinics, specialty and mail pharmacy support, and related consumer health services. Recurring company news includes quarterly results and guidance, segment performance across Health Services, Health Care Benefits, and Pharmacy & Consumer Wellness, and capital returns through common-stock dividends.
Updates also cover CVS Caremark formulary decisions, biosimilar adoption, Aetna prior authorization and plan-administration initiatives, community health investments by the CVS Health Foundation, and developments involving Omnicare, the company's long-term care pharmacy subsidiary.
CVS Health (NYSE: CVS) plans to separate into two independent, publicly traded companies, with completion expected in the first half of 2028. The healthcare solutions company, provisionally called CVS Health, will include Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health. CVS Pharmacy will include approximately 9,000 pharmacies, mail pharmacy, MinuteClinic and Health100.
Shareholders will own shares in both companies. The separation is intended to be tax-free for U.S. federal income tax purposes. CVS Health expects both businesses to have investment-grade ratings, free cash flow to fund investment and dividends, and separate capital structures. Completion requires final board approval, an effective Form 10 registration statement and confirmation of tax-free treatment. CVS Health also raised its full-year 2026 guidance alongside separately announced third-quarter results.
CVS Health (CVS) raised its full-year 2026 earnings and operating cash flow guidance after reporting higher third-quarter revenue and profit. Revenue rose 5.4% to $108.4 billion. GAAP diluted earnings per share were $1.68, versus a $3.13 loss a year earlier, when results included a $5.7 billion goodwill impairment. Adjusted EPS increased to $2.09 from $1.60.
Full-year guidance now calls for GAAP diluted EPS of at least $6.98, adjusted EPS of at least $8.20 and operating cash flow of at least $15.5 billion. Year-to-date operating cash flow reached $15.3 billion. All operating segments increased adjusted operating income. Health Care Benefits' medical benefit ratio, the share of premiums spent on care, improved to 91.3% from 92.8%. Pharmacy & Consumer Wellness revenue fell 2.0%. CVS maintained a cautious outlook because of elevated cost trends and potential macroeconomic headwinds.
CVS Health (CVS) announced Aetna’s Q3 provider survey findings, with average payer-provider trust at 6.0 on a 10-point scale. That compares with 6.1 in Q2 and 5.4 in Q1; the results reflect providers’ views of payers generally, not Aetna alone.
Administrative burden was the top current challenge for 67% of providers, down seven percentage points from Q2. Among those citing it as a top challenge, 27% named prior authorization as the leading contributor, down from 31%. Updating patient medical records was the biggest contributor for 58%, up five percentage points. Nearly 1 in 3 providers chose real-time patient information as the most important action payers could take to address current challenges.
Fraud, waste and abuse was identified as a problem needing attention by 94% of respondents. Close to 60% saw lower overall health care costs as the top benefit of addressing it.
CVS Health (NYSE: CVS) announced that its CVS Pharmacy retail division is expanding its fall assortment of collectibles and seasonal products. Offerings span toys, beauty and snacks, including Pokémon trading cards and CVS-exclusive seasonal items. Products are rolling out at participating stores and CVS.com, with selection, timing and availability varying by location and while supplies last. Holiday treats will arrive in November.
CVS Health (CVS) has opened three MinuteClinic locations in Massachusetts, including its first clinic in the city of Boston. The clinics are inside CVS Pharmacy locations in Charlestown, Beverly and Swampscott. They provide preventive and acute care for patients 18 months and older, seven days a week, including evenings and weekends. Patients can walk in or book through the CVS Health app or MinuteClinic.com.
CVS Health (CVS) announced a collaboration with The Midlife Collective to study women’s experiences and needs during midlife.
The organizations will conduct research covering health, identity, caregiving, relationships, career transitions, financial wellbeing and personal fulfillment. Findings will help inform Her Second Act, The Midlife Collective’s documentary currently in development. The collaboration combines research and storytelling, with the aim of improving understanding of women’s midlife experiences and identifying where additional support may be needed.
CVS Health (CVS) announced MinuteClinic's seventh consecutive Joint Commission accreditation, including its first evaluation of primary care locations under Medical Center standards.
The accreditation is valid for up to three years and covers medical services at more than 800 locations nationwide and MinuteClinic Virtual Care. Surveyors evaluated more than 80 sites across 17 states and Washington, D.C., from July 13 to 17, 2026. Approximately 80 percent of surveyed locations offer primary care and were evaluated under Medical Center standards, which emphasize ongoing care, referrals and follow-up. Primary care is now available at more than 65 percent of MinuteClinic locations for patients 18 and older.
CVS Health (NYSE: CVS) subsidiary Aetna reported that most Medicare Advantage members are in highly rated 2027 plans. More than 69 percent are in plans rated 4 stars or higher by the Centers for Medicare & Medicaid Services, on a five-star scale.
Clinical measure scores included 4.77 for Plan All-Cause Readmissions, 5.00 for older adults' medication review and 4.03 for older adults' functional status assessment. Colorectal and breast cancer screening scored 4.19 and 4.07, respectively. Customer Service scored 4.04, Getting Needed Care scored 3.89 and Getting Needed Prescription Drugs scored 4.07. Interpreter and teletypewriter availability scored 4.99.
The results use CMS 2027 Star Ratings data published October 8, 2026, and Medicare Advantage and Medicare Advantage prescription drug enrollment as of September 2026. Individual plan ratings may vary.
CVS Health (CVS) unveiled its first pharmacy-focused CVS Pharmacy in the Boston area, adding a location in Roxbury.
The pharmacy at 32 Warren Street provides medications, immunizations and other pharmacist services. CVS plans nearly 20 pharmacy-focused locations in 2026 in select communities nationwide. These sites average around 3,000 square feet and combine a full-service pharmacy with a customized selection of over-the-counter products. Items not stocked can be ordered with free home delivery. The Roxbury location also offers medication disposal and used-needle collection. Separately, the company plans more than 40 new CVS Pharmacy locations this year, including traditional stores and pharmacies in Target.
CVS Health (CVS) is reminding New Yorkers that measles-mumps-rubella (MMR) vaccinations are available statewide for eligible patients amid a measles outbreak.
Vaccines are available at more than 530 CVS Pharmacy locations for patients ages 3 and older. MinuteClinic offers the recommended second dose for children ages 4 to 6. Neither offers the first routine dose, typically given at 12 to 15 months. Walk-ins are welcome; advance appointments are encouraged.